Skip to content

Farbridge Pharma Consulting

Active Risk: not assessed Private limited companyfounded 2026active for less than a yearTraverse d'Esope 6, 1348 Ottignies-Louvain-la-NeuveKBO/BCE: BE 1037.954.933
Farbridge Pharma Consulting
Follow ReportCompare

Board

1 director, since incorporation
VERBRUGGHE Stéphanie Marie Anne
Director (not named in the articles)
appointed by deed of 18-05-2026 term without a fixed end

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
VERBRUGGHE Stéphanie Marie Anne
Director (not named in the articles)
Board
Mandates as a list
  • VERBRUGGHE Stéphanie Marie Anne
    • Director (not named in the articles), appointed by deed of 18-05-2026, still in office

Control

Founders
VERBRUGGHE Stéphanie Marie Anne, VERBRUGGHE Stéphanie
This company
Farbridge Pharma Consulting

Capital

Contribution
€5,500
Shares
100
Contribution per share
€55
Source
deed of 18-05-2026

Articles of association

deed of 18-05-2026 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 January to 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Friday of June at 16:00 (the first on 18-06-2027)
Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor

Shareholders

At incorporation deed of 18-05-2026 ↗

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure